Sichuan Gangtong Medical Equipment Group Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000066Q7
CNY
25.92
5.82 (28.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Debt Company with a Debt to Equity ratio (avg) at times

  • Poor long term growth as Net Sales has grown by an annual rate of -17.81% and Operating profit at -150.56% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 6.97% signifying low profitability per unit of shareholders funds
2

Poor long term growth as Net Sales has grown by an annual rate of -17.81% and Operating profit at -150.56% over the last 5 years

 
3

With a fall in Net Sales of -33.47%, the company declared Very Negative results in Mar 25

4

Risky -

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 479 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.23

stock-summary
Return on Equity

-1.55%

stock-summary
Price to Book

0.39

Revenue and Profits:
Net Sales:
78 Million
(Quarterly Results - Sep 2025)
Net Profit:
-3 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
33.75%
0%
33.75%
6 Months
25.22%
0%
25.22%
1 Year
36.56%
0%
36.56%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Sichuan Gangtong Medical Equipment Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-17.81%
EBIT Growth (5y)
-150.56%
EBIT to Interest (avg)
25.86
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.55
Tax Ratio
10.41%
Dividend Payout Ratio
165.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.22%
ROE (avg)
6.97%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.40
EV to EBIT
-5.05
EV to EBITDA
-10.57
EV to Capital Employed
0.15
EV to Sales
0.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.00%
ROE (Latest)
-0.95%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 40.97% vs -37.82% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -158.70% vs 202.22% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "78.10",
          "val2": "55.40",
          "chgp": "40.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.00",
          "val2": "5.80",
          "chgp": "-168.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "1.30",
          "chgp": "30.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.70",
          "val2": "4.60",
          "chgp": "-158.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-50.60%",
          "val2": "45.10%",
          "chgp": "-9.57%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -10.50% vs 9.82% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -82.67% vs 12.45% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "750.90",
          "val2": "839.00",
          "chgp": "-10.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.10",
          "val2": "75.90",
          "chgp": "-82.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.00",
          "val2": "4.70",
          "chgp": "48.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.10",
          "val2": "-0.20",
          "chgp": "1,150.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.40",
          "val2": "83.10",
          "chgp": "-82.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.20%",
          "val2": "78.90%",
          "chgp": "-7.87%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
78.10
55.40
40.97%
Operating Profit (PBDIT) excl Other Income
-4.00
5.80
-168.97%
Interest
1.70
1.30
30.77%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.70
4.60
-158.70%
Operating Profit Margin (Excl OI)
-50.60%
45.10%
-9.57%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 40.97% vs -37.82% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -158.70% vs 202.22% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
750.90
839.00
-10.50%
Operating Profit (PBDIT) excl Other Income
13.10
75.90
-82.74%
Interest
7.00
4.70
48.94%
Exceptional Items
2.10
-0.20
1,150.00%
Consolidate Net Profit
14.40
83.10
-82.67%
Operating Profit Margin (Excl OI)
0.20%
78.90%
-7.87%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -10.50% vs 9.82% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -82.67% vs 12.45% in Dec 2023

stock-summaryCompany CV
About Sichuan Gangtong Medical Equipment Group Co., Ltd. stock-summary
stock-summary
Sichuan Gangtong Medical Equipment Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available